Skip to Content

Cipla 458 (Fenofibrate 145 mg)

Pill with imprint Cipla 458 is White, Elliptical / Oval and has been identified as Fenofibrate 145 mg. It is supplied by Cipla USA Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 458

Fenofibrate 145 mg Cipla 458

Fenofibrate

Imprint
Cipla 458
Strength
145 mg
Color
White
Size
18.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0458
Inactive Ingredients
microcrystalline cellulose, crospovidone, docusate sodium, hypromellose 2910 (3 mPa.s), lactose monohydrate, soya lecithin, magnesium stearate, sodium lauryl sulfate, sucrose, magnesium silicate, titanium dioxide, xanthan gum

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.